RS63699B1 - Upotreba sulkardina za tretman atrijalne fibrilacije - Google Patents

Upotreba sulkardina za tretman atrijalne fibrilacije

Info

Publication number
RS63699B1
RS63699B1 RS20220986A RSP20220986A RS63699B1 RS 63699 B1 RS63699 B1 RS 63699B1 RS 20220986 A RS20220986 A RS 20220986A RS P20220986 A RSP20220986 A RS P20220986A RS 63699 B1 RS63699 B1 RS 63699B1
Authority
RS
Serbia
Prior art keywords
sulcardine
treatment
atrial fibrillation
fibrillation
atrial
Prior art date
Application number
RS20220986A
Other languages
English (en)
Inventor
Gary T Elliot
Yiping Wang
Donglu Bai
Original Assignee
Huyabio International Llc
Shanghai Institute Of Materia Medica Chinese Academy Of Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huyabio International Llc, Shanghai Institute Of Materia Medica Chinese Academy Of Sciences filed Critical Huyabio International Llc
Publication of RS63699B1 publication Critical patent/RS63699B1/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
RS20220986A 2009-11-17 2010-11-16 Upotreba sulkardina za tretman atrijalne fibrilacije RS63699B1 (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26192509P 2009-11-17 2009-11-17
EP17182709.0A EP3311810B1 (en) 2009-11-17 2010-11-16 Use of sulcardine for the treatment of atrial fibrillation

Publications (1)

Publication Number Publication Date
RS63699B1 true RS63699B1 (sr) 2022-11-30

Family

ID=44060290

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20220986A RS63699B1 (sr) 2009-11-17 2010-11-16 Upotreba sulkardina za tretman atrijalne fibrilacije

Country Status (11)

Country Link
US (1) US8541464B2 (sr)
EP (2) EP2501381B1 (sr)
JP (2) JP6116908B2 (sr)
CN (3) CN102665714A (sr)
DK (2) DK3311810T3 (sr)
ES (2) ES2644818T3 (sr)
HK (1) HK1254495A1 (sr)
HU (2) HUE034007T2 (sr)
PL (2) PL2501381T3 (sr)
RS (1) RS63699B1 (sr)
WO (1) WO2011062906A2 (sr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6116907B2 (ja) * 2009-11-17 2017-04-19 フヤ バイオサイエンス インターナショナル エルエルシー サルカルディン及びその塩の緩速点滴
JP6116908B2 (ja) * 2009-11-17 2017-04-19 フヤ バイオサイエンス インターナショナル エルエルシー 心房細動の治療
SG2013035662A (en) 2013-05-08 2014-12-30 Menicon Singapore Pte Ltd Systems and methods for printing on a contact lens
CA3123078A1 (en) 2018-12-13 2020-06-18 Huya Bioscience International, Llc Sulcardine administration for treatment of acute atrial fibrillation
CA3128152A1 (en) * 2019-01-29 2020-08-06 Huya Bioscience International, Llc Sulcardine salts
CN112516136B (zh) * 2019-09-17 2024-03-01 中国科学院上海药物研究所 硫酸舒欣啶在制备抗心衰产品中的应用
KR20230024347A (ko) 2020-06-12 2023-02-20 후야바이오 인터내셔널, 엘엘씨 급성 심방 세동의 치료를 위한 설카르딘 투여
CN114984004B (zh) * 2022-05-25 2023-09-12 扬州中宝药业股份有限公司 硫酸舒欣啶在制备抗脓毒症药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1172908C (zh) * 1999-12-10 2004-10-27 中国科学院上海药物研究所 N-取代苄基或苯基芳香磺酰胺化合物及其用途
CN1939298A (zh) * 2005-09-29 2007-04-04 中国科学院上海药物研究所 硫酸舒欣啶固体和靶向制剂及其制备方法
JP6116907B2 (ja) * 2009-11-17 2017-04-19 フヤ バイオサイエンス インターナショナル エルエルシー サルカルディン及びその塩の緩速点滴
JP6116908B2 (ja) * 2009-11-17 2017-04-19 フヤ バイオサイエンス インターナショナル エルエルシー 心房細動の治療

Also Published As

Publication number Publication date
CN105362264A (zh) 2016-03-02
PL2501381T3 (pl) 2018-02-28
EP2501381B1 (en) 2017-07-26
ES2929185T3 (es) 2022-11-25
CN102665714A (zh) 2012-09-12
EP2501381A4 (en) 2013-06-12
DK2501381T3 (da) 2017-11-06
HUE034007T2 (en) 2018-01-29
DK3311810T3 (da) 2022-10-24
US20120309810A1 (en) 2012-12-06
EP3311810A1 (en) 2018-04-25
WO2011062906A2 (en) 2011-05-26
HUE060876T2 (hu) 2023-04-28
PL3311810T3 (pl) 2022-12-05
CN104324024A (zh) 2015-02-04
HK1254495A1 (zh) 2019-07-19
WO2011062906A8 (en) 2012-02-09
EP3311810B1 (en) 2022-07-27
JP2013511473A (ja) 2013-04-04
ES2644818T3 (es) 2017-11-30
JP6116908B2 (ja) 2017-04-19
EP2501381A2 (en) 2012-09-26
US8541464B2 (en) 2013-09-24
WO2011062906A9 (en) 2011-10-06
JP2016028054A (ja) 2016-02-25

Similar Documents

Publication Publication Date Title
HK1254495A1 (zh) 舒巴林用於治療心房纖顫的用途
HK1165332A1 (en) Compositions and methods for preventing cardiac arrhythmia
AP3536A (en) Method of treating atrial fibrillation
HK1223274A1 (zh) 用於治療淺表病變的組合物
EP2817061A4 (en) IMPROVEMENTS IN ABLATION TECHNIQUES FOR THE TREATMENT OF ATRIAL FIBRILLATION
EP2654745A4 (en) COMPOSITION FOR TREATING SKIN CONDITIONS OF THE SKIN
HK1167391A1 (en) Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
PL2460509T3 (pl) Kompozycja do leczenia brodawek
SI2531124T1 (sl) Naprava za zdravljenje kožnih lezij
ZA201005770B (en) The treatment of damaged skin
HK1204262A1 (en) Method of treating atrial fibrillation
GB0809319D0 (en) The treatment of puritus
GB0906210D0 (en) Compounds for the treatment of flaviviral
GB0901175D0 (en) The treatment of skin aging